Hepatitis C News and Research

Latest Hepatitis C News and Research

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

After unanimously voting to recommend a miraculous hepatitis C drug for approval in 2013, a panel of experts advising the Food and Drug Administration gushed about what they'd accomplished.

5 Nov 2019

Deaths from liver cancer increased 3-fold over 20 years in England

Liver cancer is rapidly moving up the cancer killer ranks in England, according to a new study that is to be presented at the 201th NCRI Cancer Conference on November 2, 2019. Both the number of new cases and the mortality rate from hepatocellular carcinoma (HCC), have tripled, over the period from 1997 to 2016. HCC is the most common form of liver cancer. Moreover, a quarter of these cases occur among the least privileged fifth of society.

3 Nov 2019

Measles wipes out other immune memories

Thanks to misinformation and anti-vaccination campaigns in some pockets, United States and several nations of Europe have seen a massive outbreak of vaccine preventable measles infection over the recent years.

3 Nov 2019

Study shows how measles virus causes immune amnesia

Over the last decade, evidence has mounted that the measles vaccine protects in not one but two ways: Not only does it prevent the well-known acute illness with spots and fever that frequently sends children to the hospital, but it also appears to protect from other infections over the long term.

31 Oct 2019

OHSU receives $2.1 million to develop new vaccine additives for tropical viruses

Sometimes vaccines need a little help to protect people against infectious diseases.

31 Oct 2019

New contrast agent improves MRI diagnosis of early liver fibrosis

A new compound has been invented to bind to liver cells that are in the early stages of damage, thus making it easier to pick them up using MRI (magnetic resonance imaging).

30 Oct 2019

Rilpivirine drug used for HIV treatment also suppresses Zika virus infection

Like an adjustable wrench that becomes the "go-to" tool because it is effective and can be used for a variety of purposes, an existing drug that can be adapted to halt the replication of different viruses would greatly expedite the treatment of different infectious diseases.

30 Oct 2019

MRI contrast agent enables early detection of liver disease

Researchers have developed a new MRI contrast dye that enables more accurate and safer detection of early-stage liver disease than currently approved agents.

30 Oct 2019

Hospitals take shot at opioid makers over cost of treating uninsured for addiction

While thousands of cities and counties have banded together to sue opioid makers and distributors in a federal court, another group of plaintiffs has started to sue on their own: hospitals.

29 Oct 2019

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

When a long, black bus bearing the logo of drugmaker AbbVie rolls through Washington state next year, it will promote a new effort to eradicate hepatitis C infections.

25 Oct 2019

Study shows why fatty liver disease contributes to increase in liver cancer

Fatty liver disease is contributing to an increase in liver cancer and basic scientists at The University of Texas Health Science at Houston have new insight as to why.

16 Oct 2019

Cancer Atlas: Progress in the fight against cancer is not only possible, but achievable

The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable.

16 Oct 2019

Syphilis rates in patients with kidney failure found to be greater than general population

Syphilis rates, like other sexually transmitted disease rates in the United States, are soaring, and the first known study to examine syphilis rates in patients with kidney failure found an incidence greater than three times that of the general population.

16 Oct 2019

Hawaii STD epidemic driven by social media and dating apps

There is a sharp rise in the number of cases of sexually transmitted diseases in the United States say health officials. Remarkable rise has been noted in Hawaii and has been attributed to the popularity of online dating and sexual intercourse with multiple partners.

15 Oct 2019

People with PTSD 1.8 times as likely to have other infections, study finds

First-of-its-kind study finds people with PTSD were 1.8 times as likely to have any infection as those without PTSD, ranging from being 1.3 times as likely to have meningitis, to 1.7 times as likely to have influenza, to 2.7 times as likely to have viral hepatitis.

15 Oct 2019

New findings highlight the 'PrEP gap' for men who have sex with men in the EU

This estimate on the "PrEP gap" in Europe was published in a paper in Eurosurveillance today stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.

11 Oct 2019

Congenital syphilis continues to rise at an alarming rate

One of the nation's most preventable diseases is killing newborns in ever-increasing numbers.

8 Oct 2019

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.

3 Oct 2019

Wistar awarded more than $12 million to study opioid use in HIV-infected people

The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.

24 Sep 2019

Explosion at biofacility in Russia raises concerns over safety: Should we be worried?

A Russian research facility which holds one of the world's largest collections of viruses has suffered an explosion, triggering concerns over potential biological contamination.

18 Sep 2019

Hepatitis C News and Research

Latest Hepatitis C News and Research

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

Deaths from liver cancer increased 3-fold over 20 years in England

Measles wipes out other immune memories

Study shows how measles virus causes immune amnesia

OHSU receives $2.1 million to develop new vaccine additives for tropical viruses

New contrast agent improves MRI diagnosis of early liver fibrosis

Rilpivirine drug used for HIV treatment also suppresses Zika virus infection

MRI contrast agent enables early detection of liver disease

Hospitals take shot at opioid makers over cost of treating uninsured for addiction

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

Study shows why fatty liver disease contributes to increase in liver cancer

Cancer Atlas: Progress in the fight against cancer is not only possible, but achievable

Syphilis rates in patients with kidney failure found to be greater than general population

Hawaii STD epidemic driven by social media and dating apps

People with PTSD 1.8 times as likely to have other infections, study finds

New findings highlight the 'PrEP gap' for men who have sex with men in the EU

Congenital syphilis continues to rise at an alarming rate

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

Wistar awarded more than $12 million to study opioid use in HIV-infected people

Explosion at biofacility in Russia raises concerns over safety: Should we be worried?

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in